Dec. 16, 2024 — To fight the virus that causes influenza, one of the avenues being explored by scientists is the development of drugs capable of destabilizing its genome, made up of RNA molecules.

“Some of it is influenza, the virus itself because it’s a segmented RNA and has a different genome. It behaves differently than some viruses, it can mix and match and reassort. So that’s, that’s one ...

Influenza viruses are among the most likely triggers of future pandemics. A research team has developed a method that can be used to study the interaction of viruses with host cells in unprecedented ...

The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years ...

The genome incorporation mechanism for LINE-1, the only autonomously active retrotransposon in humans, leverages the cell ...

At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...

LAUSANNE, Switzerland & SAN DIEGO, May 02, 2025--(BUSINESS WIRE)--HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram ...

A tiny chemical modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators.

Highly pathogenic forms of avian influenza, like H5N1, are thought to have caused the deaths of millions of birds around the world, both wild and farmed. Scientists have recently found that one strain ...

Effective mucosal immunity in the intestine involves a fine balance between tolerance of the microbiome, recognition and elimination of pathogens, and inflammatory tissue injury. The anti-inflammatory ...